Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00560885 · ClinicalTrials.gov registry record · Phase 3
AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation
A Phase 3 study, sponsored by AtriCure.
- Completed
- Registry status
- Phase 3
- Development phase
- 55
- Enrollment target
NCT00560885 is a Phase 3 study that has completed, run by AtriCure. The registered enrollment target is 55 participants.
The verdict
NCT00560885, a Phase 3 study, has completed, sponsored by AtriCure.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 55 participants
- Enrollment target
Study Summary
ABLATE is a prospective, non-randomized multi-center clinical trial to demonstrate the safety and effectiveness of the AtriCure Bipolar System for treating permanent atrial fibrillation during concomitant on-pump cardiac surgery.
Interventions
- DEVICE AtriCure Bipolar System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2007-11 |
| Est. Completion | 2012-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00560885
The ClinicalTrials.gov registry entry for NCT00560885 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AtriCure, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AtriCure Bipolar System is the first listed.
NCT00560885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00560885 about?
NCT00560885 is a clinical study titled "AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation". ABLATE is a prospective, non-randomized multi-center clinical trial to demonstrate the safety and effectiveness of the AtriCure Bipolar System for treating permanent atrial fibrillation during concomitant on-pump cardiac surgery.
What is the current status of trial NCT00560885?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 55 participants. The study started on 2007-11. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00560885?
The interventions under investigation include: AtriCure Bipolar System (DEVICE).
Who is sponsoring clinical trial NCT00560885?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.